Pathology 24.11.2020 11.14.22.470
Pathology 24.11.2020 11.14.22.470
Pathology 24.11.2020 11.14.22.470
2020 12:42AM
PATIENT : Ms. TRISHA HALDER RECEIVED : 24.11.2020 5:45PM
AGE/SEX : 26 Y / Female REPORTED : 24.11.2020 11:11PM
REF. BY : Dr. SELF SRF ID : 1930300339203
CENTER : A-OPD
INTERPRETATION:
Result Remarks
Limitations:
a) Covid 19 Qualitative RT PCR test is an in vitro qualitative PCR assay for the qualitative
detection of Novel Corona Virus 2019 in respiratory specimens
b) Test is conducted on Nasopharyngeal swab/ Oropharyngeal swabs and other respiratory
specimens collected in viral transport media.
c) Detection of confirmatory genes indicates presence of SARS-CoV-2 RNA in the specimen
tested.
d) Negative results do not preclude SARS-CoV-2 infection and should not be used as the sole
basis for patient management decisions. They must be correlated with clinical observations,
patient history and epidemiological information.
e) Mutations or polymorphisms in the primer and probe binding sites, presence of PCR inhibition
due to host factors may also cause false negative results.
f) Fresh sample for RT PCR can be considered after a gap of 2-4 days if there is a strong clinical
suspicion/contact of Covid 19 patient
g) Repeat sampling and testing of lower respiratory specimen is strongly recommended in a
severe or progressive disease.
Note:
1. ICMR-Registration Number : RBDIAPLKWB
2. COVID-19 test is conducted with a kit approved by ICMR/CE-IVD/US-FDA.
3. Kindly consult Referring Physician/Authorized Government Hospital for appropriate follow up.
Prepared by Dr. TRIDIP CHATTERJEE Dr. SIMONTINI PATRA BANERJEE Dr. NILAY CHATTERJEE
Ph. D (Molecular Biologist) MD(Microbiology) Consultant Microbiologist PhD (Microbiology)